Skip to content

Autologous Bone Marrow-derived Mesenchymal Stem Cells (BMSCs) Transplantation for ovarian function recovery on Premature Ovarian Insufficiency (POI) patients

Autologous Bone Marrow-derived Mesenchymal Stem Cells (BMSCs) Transplantation for ovarian function recovery on Premature Ovarian Insufficiency (POI) patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015944
Enrollment
Unknown
Registered
2018-05-02
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ovarian Insufficiency

Interventions

Case series:Single side ovary injection of autologous BMSCs

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Female aged between 18-40 years old; 2. Menorrhea or oligomenorrhea at least for 3-6 months; 3. FSH level above 25 IU/L (repeated twice >4 weeks apart); 4. Presence of bilateral ovary; 5. No combined with male infertility; 6. Normal karyotype 46, XX; 7. Normal prolactin level within one year of study initiation; 8. Normal thyroid function as evidence by normal serum TSH levels; 9. Willing to attempt to get pregnant as part of the experimental protocol.Agree to report any pregnancy to the research staff immediately; 10.Willing and able to comply with study requirements.

Exclusion criteria

Exclusion criteria: 1. History of gynecologic malignancy and pelvic surgery; 2. Contraindication to surgery or anesthesia; 3. Combined with major physical illnesses or mental disorders, such as heart diseases, Type I or Type II diabetes mellitus, significant anemia that precludes performance of surgery;

Design outcomes

Primary

MeasureTime frame
Resumption of Menses;Improvement in hormone levels (FSH, LH, E2, P, Anti-Mullerian Hormone);Number of mature follicle;

Secondary

MeasureTime frame
Occurrence of pregnancy;Endometrium thickness;

Countries

China

Contacts

Public ContactAiping Qin

The First Affiliated Hospital of Guangxi Medical University

aipingqin@gmail.com+86 13977102456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026